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Abstract
Background: Cystic fibrosis is a debilitating lung disease due to mutations in the cystic fibrosis transmembrane
conductance regulator protein (CFTR) and is associated with chronic infections resulting in elevated
myeloperoxidase activity and generation of hypochlorous acid (HOCl). CFTR mutations lead to decreased levels of
glutathione (GSH) and thiocyanate (SCN) in the epithelial lining fluid (ELF). Hypertonic saline is used to improve
lung function however the mechanism is uncertain.
Methods: In the present study, the effect of GSH and SCN on HOCl-mediated cell injury and their changes in the
ELF after hypertonic saline nebulization in wild type (WT) and CFTR KO mice was examined. CFTR sufficient and
deficient lung cells were assessed for GSH, SCN and corresponding sensitivity towards HOCl-mediated injury, in
vitro.
Results: CFTR (-) cells had lower extracellular levels of both GSH and SCN and were more sensitive to HOCl-
mediated injury. In vivo, hypertonic saline increased ELF GSH in the WT and to a lesser extent in the CFTR KO mice
but only SCN in the WT ELF. Finally, potential protective effects of GSH and SCN at concentrations found in the
ELF against HOCl toxicity were examined in vitro.
Conclusions: While the concentrations of GSH and SCN associated with the WT ELF protect against HOCl toxicity,
those found in the CFTR KO mice were less sufficient to inhibit cell injury. These data suggests that CFTR has
important roles in exporting GSH and SCN which are protective against oxidants and that hypertonic saline
treatment may have beneficial effects by increasing their levels in the lung.
Introduction
Cystic fibrosis (CF) can result in impaired pulmonary
function from defects in mucus clearance resulting in
chronic infections and inflammation. CF is caused by a
mutation in the cystic fibrosis transmembrane regulator
(cftr) gene leading to deficient functional capability of
the CFTR transporter. CFTR was first discovered to be
an apical Cl
- ion channel but has since been shown to
be also involved in the transport of glutathione (GSH)
and thiocyanate (SCN), and is responsible for maintain-
ing levels of GSH and SCN in the epithelial lining fluid
(ELF) [1-3]. The ELF hydrates the airway surfaces and
provides a protective barrier against pathogens and air
pollutants. The imbalance of ion transport across the
lung epithelia in CF can lead to defective mucocilliary
clearance which is thought to increase the risk of devel-
oping lung infections [4]. Lung pathogens can also sti-
mulate increases in ELF GSH, whereas failure to do so
in CFTR KO mice can result in increased lung inflam-
mation and oxidative stress [5].
At least 80% of individuals with CF harbor at least one
chronic bacterial pathogen, the most common of which
is Pseudomonas aeruginosa [6]. The mucus build up in
the CF lung can lead to an ideal environment for bacter-
ial growth and makes clearance by immune cells or anti-
biotics difficult [7]. There is a substantial increase in
neutrophil influx into the lung to fight the infection in
CF. Both myeloperoxidase (MPO) and lactoperoxidase
(LPO) are key enzymes involved in host defense. Both
enzymes can utilize H2O2 and thiocyanate (SCN) to
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MPO also utilizes Cl
- to form hypochlorous acid
(HOCl) a highly damaging oxidant [8,9]. Excess HOCl
production in the lung without adequate antioxidants
such as GSH and SCN can potentially lead to epithelial
damage and unregulated inflammatory responses.
While there is no cure for CF, there are therapies that
have shown some beneficial effects in clinical studies.
One therapy is the nebulization of hypertonic saline for
improving lung function in CF individuals [10,11]. The
hypothesis is that hypertonic saline is beneficial for the
hydration of the ELF which aids in mucocilliary clear-
ance [4]. In addition to CF, hypertonic saline inhalation
has been suggested for use in chronic obstructive pul-
monary disease (COPD), asthma, and even pneumonia
[12-14]. In the present study, the effect of hypertonic
saline treatment on both GSH and SCN in the ELF was
examined. In addition, the differential levels of GSH and
SCN in CFTR sufficient and deficient cells was charac-
terized and the corresponding sensitivity to HOCl
mediated cell death was examined. Finally the relative
increases in antioxidant concentrations observed with
hypertonic saline was tested to see if it could provide
further protection against HOCl mediated toxicity.
Materials and methods
Chemicals
All chemicals and enzymes were purchased from Sigma-
Aldrich with the exception of Myeloperoxidase (MPO)
which was purchased from Calbiochem.
Cell culture
Human lung bronchial epithelial cells either sufficient
(C38) or deficient (IB3) in CFTR expression or A549
cells were used and obtained from the American Type
Culture Collection (ATCC) [15]. The C38 cell line is
derived from the IB3 cell line with normal human CFTR
stably transfected. The A549 cells were utilized as a con-
trol non-transfected airway cell line. C38 and IB3 cells
were cultured in a transwell system at an air-liquid inter-
face using LHC-8 medium containing 10% fetal bovine
serum with antibiotics. A549 cells were cultured in
Ham’s F-12 medium supplemented with 10% FBS and
antibiotics. Cytotoxicity was mesaured by LDH released
in media. The % LDH release was calculated as [LDH
(media)/LDH(total)] × 100 as previously described [16].
MPO Enzyme System
The enzyme system contains three components; MPO,
glucose, and glucose oxidase. Glucose and glucose oxi-
dase were used to generate H2O2.T h ef u l le n z y m es y s -
tem was slightly modified [17], with final concentrations
of 3 U MPO, 40 mU glucose oxidase, and 100 mM glu-
cose added to sterile PBS. Cells were incubated for 2
and 4 hours, after which the PBS was replaced with
fresh medium and cytotoxicity was measured 24 hours
later.
Hypochlorite System
The stock concentration of sodium hypochlorite (HOCl)
was determined based on the absorbance at 290 nm (pH
12, Î = 350 M
-1 cm
-1) and diluted to the necessary con-
centration in water. A549 cells were exposed to HOCl
with or without SCN and GSH in PBS for 5 minutes. PBS
was then removed and replaced with fresh media. Cyto-
toxicity was analyzed 24 hours later by LDH release.
Animals
Adult wild-type male C57BL/6 mice were purchased
from Jackson Laboratories (Bar Harbor, ME). C57BL/6J
congenic gut-corrected Cftr KO-Tg mice that possess a
S489X truncated mutation in the murine equivalent to
CFTR and have intestinal specific expression of normal
human Cftr driven by the fatty acid binding promoter
were originally obtained from Case Western Reserve
University’s CF Animal Core, as previously described
[18]. Mice were anesthetized and exsanguinated by car-
diac puncture. Plasma was collected to determine
bronchoalveolar lavage (BAL) dilution factor by urea
analysis (Teco Diagnostics) [16]. BAL was performed by
cannulating the trachea and two 750 μL aliquots of iso-
tonic potassium phosphate buffer (50 mM) at a pH of
7.4 were instilled and collected by gentle aspiration.
Animal studies were approved by the National Jewish
Health Animal Care and Use Committee.
Hypertonic saline preparation and nebulization
Hypertonic saline was made by adding NaCl to PBS to
the desired final concentration of 7% and sterile filtered.
A Plexiglas nebulizing chamber was utilized with dimen-
sions of 21.5 × 14 × 12 cm (L × H × W). Five mice at a
time were kept in the chamber and exposed to aeroso-
l i z e di s o t o n i c( 0 . 9 % )o rh y p e r t o n i cs a l i n e( 7 % )f o r
30 minutes using a DeVilbiss pulmosonic nebulizer
(DeVilbiss). Normal or hypertonic saline was freshly
prepared and up to 10 mL was nebulized over the
30 minute exposure. Mice were sacrificed 2 hours fol-
lowing saline administration and lavaged for ELF GSH
and SCN determinations.
Measurement of Glutathione
Total glutathione (GSH) was analyzed spectrophotome-
trically in the BALF, plasma, BAL cells, and lung tissue
as previously described [19]. GSH was measured by add-
ing the standard or sample to 100 μL of a 1:1 mixture of
3u n i t s / m LG Rw i t h0 . 6 7m g / m L5 , 5 ’-Dithiobis(2-nitro-
benzoic acid) (DTNB). The reaction was initiated by the
addition of 20 μLo f0 . 6 7m g / m LN A D P Ha n dt h e
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GSSG measurements the samples were incubated with
4-vinyl pyridine for 1 h to conjugate any reduced GSH
prior to analysis, GSSG samples were analyzed the same
way as GSH samples. The limits of detection were 0.2
μM for both GSH and GSSG. Apical GSH in cell culture
was quantified using HPLC with fluorescence detection
as previously described [16]. For analysis using HPLC,
the GSH was first derivatized to monobromobimane for
30 min, the reaction was stopped by acidification using
perchloric acid and any precipitate was removed by cen-
trifugation. The fluorescent detector was set at an exci-
tation and emission wavelength of 390 and 480 nm. The
limit of detection is 0.1 μM.
Measurement of Thiocyanate
Thiocyanate (SCN) was measured spectrophotometri-
cally in BALF, lung tissue, and media with slight modifi-
cations [20]. 100 μL standard or sample was added to a
microcentrifuge tube and a final concentration of 5% tri-
chloroacetic acid (TCA) was added. The standards or
samples were then transferred to a 96-well plate in
duplicate with 50 μLp e rw e l la n d5 0μL chlorinating
reagent (197 mM Na2HPO4 and 0.6% (v/v) NaOCl) was
added. After which, 30 μL colorimetric reagent (463
mM NaOH, 224 mM 1,3-dimethylbarbituric acid, 232
mM isonicotinic acid) was added. The plate was placed
in the dark to incubate for 5 min, after which the absor-
bance at 607 nm was determined using a SpectraMax
340PC plate reader. The sample concentration was
based on an 8 point standard curve made from known
concentrations of NaSCN.
Statistical analysis
Data are expressed as the mean ± standard error of the
mean. Prizm version 5 (GraphPad, San Diego, CA) was
used to perform one or two way ANOVA statistical ana-
lysis with a Bonferroni multiple comparison test. A p <
0.05 was considered significant.
Results
Hypochlorous (HOCl) elicits comparable toxicity to MPO
MPO is involved in host defense and is released by neu-
trophils to help fight bacterial infections. MPO can uti-
lize H2O2 and Cl
- to produce HOCl, a highly damaging
oxidant. The toxicity of a complete MPO system was
tested with 2 and 4 hour exposures in lung A549 cells
(Fig 1A). Glucose and glucose oxidase was used to gen-
erate H2O2, resulting in increased toxicity by itself.
When MPO was added, the toxicity was significantly
increased over the control levels at both 2 and 4 hours.
To establish a relative concentration of HOCl that elicits
the same level of toxicity as the MPO system, A549 cells
were exposed to HOCl in PBS for 5 min at varying con-
centrations (Fig 1B). Cell toxicity increased in a concen-
tration dependant manner with HOCl. The
concentration of HOCl resulting in 100% toxicity was
1200 μM HOCl, whereas the lower HOCl concentration
of 750 μM produced roughly 65% toxicity and was com-
parable to the MPO after a 2 hour exposure.
CFTR deficiency increases sensitivity to HOCl mediated
toxicity
The ability to maintain elevated levels of antioxidants in
the extracellular space is critical since the MPO and the
corresponding HOCl that is generated are largely extra-
cellular. CFTR is responsible for maintaining GSH and
SCN, both important antioxidants involved in the detox-
ification of HOCl. GSH (Fig 2A) and SCN (Fig 2B) were
measured in the extracellular and intracellular compart-
ments of both CFTR (+) and CFTR (-) cell lines grown
on an air liquid interface. Basal extracellular GSH and
Figure 1 HOCl elicits comparable toxicity to MPO. A549 cells were exposed to MPO for 2 and 4 hours (A) or HOCl for 5 minutes (B) and
toxicity was compared 24 hours after the exposure. MPO requires H2O2 to catalyze the formation of HOCl, therefore the glucose/glucose
oxidase (GOX) system was utilized to produce H2O2. The MPO/GOX showed significant increases in toxicity at both 2 and 4 hour exposures. In
comparison, HOCl alone produced a concentration dependant increase in toxicity. Roughly 750 μM HOCl exhibited similar toxicity as MPO at
2 hours. Data presented as mean ± SEM, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 compared to controls.
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of the CFTR (+) cell line. To determine if the decrease
in antioxidant capacity in the CFTR (-) cell line results
in increased sensitivity to oxidants, both cell lines were
treated with HOCl at increasing concentrations (Fig
2C). While the HOCl concentrations between 50 and
250 μMw e r en o tt o x i cf o rt h eC F T R( + )c e l l s ,t h e
CFTR (-) cells exhibited a 3-fold increase in HOCl
mediated toxicity at 250 μM showing that the CFTR (-)
cells are more sensitive to HOCl mediated toxicity.
Hypertonic saline increases ELF GSH and SCN and is
dependant on CFTR
T h ei n h a l a t i o no fh y p e r t o n i cs a l i n ei so n et h e r a p yf o r
CF, and these studies sought to determine if this therapy
has any beneficial effects at increasing GSH or SCN in
the airways. Both CFTR KO and WT mice were either
exposed to nebulized isotonic (0.9%) or hypertonic (7%)
saline, to control for potential effects of isotonic saline,
unexposed mice were also evaluated. The CFTR KO
mice had roughly half the basal ELF GSH levels as com-
pared to the WT mice, with levels only reaching 51 μM
GSH compared to 127 μM GSH (Fig 3A). While the iso-
tonic saline had no effect on WT ELF GSH, the CFTR
KO mice did exhibit a small increase in GSH up to 74
μM. Conversely, WT mice exposed to hypertonic saline
had roughly twice the amount of ELF GSH with levels
reaching 248 μM compared to only 123 μMi nt h e
CFTR KO mice. In addition, BAL cell GSH levels were
increased in the WT mice but not in the CFTR KO
mice with hypertonic saline exposure (Fig 3B).
While GSH is a primary antioxidant in the ELF, SCN
is also an important antioxidant at detoxifying HOCl
from excess MPO activity and is dependent on CFTR to
be exported into the ELF. ELF SCN levels were mea-
sured in both the WT and CFTR KO mice after expo-
sure to either isotonic or hypertonic saline (Fig 3C). The
WT mice did show an increase in ELF SCN with the
hypertonic saline exposure, while the CFTR KO mice
did not exhibit increases in SCN. This suggests that
while hypertonic saline may afford some protection by
increasing GSH in CFTR KO airways, this protective
response is limited by the inability to elevate their
already deficient ELF SCN levels.
Hypertonic saline does not affect lung tissue levels of
GSH or SCN
S i n c eh y p e r t o n i cs a l i n ed o e si n c r e a s et h eE L Fl e v e l so f
b o t hG S Ha n dS C Ni nW Tm i c e ,t h el u n gt i s s u eG S H
and SCN levels were measured to determine whether
the intracellular levels are also increased. Hypertonic
Figure 2 Cftr deficiency sensitizes cells to HOCl mediated
toxicity. The levels of both extracellular and intracellular GSH (A)
and SCN (B) were examined in cells either sufficient (C38) or
deficient (IB3) in CFTR grown on an air liquid interface. In addition,
both the CFTR sufficient and deficient cells were treated HOCl (C) to
examine cell sensitivity. Data presented as mean ± SEM, *p ≤ 0.05,
**p ≤ 0.01, ***p ≤ 0.001 compared between CFTR (+) and CFTR (-)
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GSH (Fig 4A) or GSSG (Fig 4B). To confirm that the
intracellular GSH steady-state levels were not changing
t h er a t el i m i t i n ge n z y m ei nG S Hs y n t h e s i s ,g-glutamyl-
cysteine ligase (GCL), was examined and no increases in
GCL expression were found (data not shown).
CFTR is one of the main apical transporters of SCN in
the lung; therefore studies to determine whether intra-
cellular SCN was higher in the CFTR KO mice com-
pared to the WT mice were conducted (Fig 4C).
Intracellular SCN was roughly 35% higher in the unex-
posed CFTR KO mice compared to the WT. While
there were no differences between CFTR KO and WT
with both isotonic and hypertonic saline exposure.
The concentrations of GSH and SCN achieved by
hypertonic saline protect cells against HOCl mediated
toxicity
Since hypertonic saline is able to increase ELF GSH but
not SCN, studies to determine whether this could have
significant implications for the detoxification of HOCl
were conducted (Fig 5). The same concentrations of
Figure 3 Hypertonic saline exposure increases levels of
antioxidant thiols in the ELF. Either WT or gut corrected CFTR KO
mice were exposed to hypertonic (7%) or isotonic (0.9%) saline for
30 minutes and the antioxidant response was examined in the ELF
2 hours later. Hypertonic saline increases ELF GSH (A) in both the
WT and CFTR KO mice, but the CFTR KO levels only increased back
up to basal levels of the WT mice. Hypertonic saline also increases
the BAL cell GSH (B) in the WT but not CFTR KO mice. Finally,
hypertonic saline increases ELF SCN (C) in the WT mice but not the
CFTR KO mice. Data presented as mean ± SEM, *p ≤ 0.05,
**p ≤ 0.01, ***p ≤ 0.001 compared to respective unexposed control
or between WT and CFTR KO.
Figure 4 Hypertonic saline does not affect tissue levels of GSH
or SCN. Since hypertonic saline can produce a mild osmotic stress
on the lung the levels GSH (A) and GSSG (B) were examined in the
lung tissue. Hypertonic saline did not alter the tissue levels of either
GSH or GSSG in the WT or CFTR KO mice. In addition, tissue SCN
levels (C) were examined and found to be higher in the CFTR KO
unexposed lung compared to the WT, but neither hypertonic nor
isotonic saline showed any effect on these levels. Data presented as
mean ± SEM, *p ≤ 0.05 compared between WT and CFTR KO.
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assess their combined effects on the toxicity of HOCl.
To replicate the concentrations in the ELF, four differ-
ent combinations of GSH and SCN were used. To
represent the basal WT ELF levels, 100 μMG S Ha n d
100 μM SCN were used in combination. To represent
the WT ELF levels after hypertonic saline exposure, 250
μMG S Ha n d1 7 5μM SCN was used. To represent the
basal CFTR KO ELF levels, 50 μMG S Ha n d2 5μM
SCN was used. Finally, to represent the CFTR KO levels
after hypertonic saline exposure, 100 μMG S Ha n d2 5
μMS C Nw a su s e d .7 5 0μM HOCl alone produced
roughly 65% toxicity while both combinations of GSH
and SCN that represent the WT ELF exhibited complete
protection against this level of HOCl-mediated injury
(Fig 5A). In addition, while there was still some protec-
tion afforded by the concentrations of GSH and SCN
found in the CFTR KO ELF, HOCl mediated toxicity
was significantly higher than representative WT levels.
The 50 μM GSH and 25 μM SCN levels associated with
CFTR KO basal ELF showed roughly 25% LDH release,
while the concentrations that represent the CFTR KO
ELF exposed to hypertonic saline did significantly
decrease the HOCl mediated toxicity at roughly 15%
toxicity, which was still higher than the control. To
examine whether protective effects occurred at higher
HOCl concentrations, 1200 μM HOCl was used (Fig
5B). HOCl (1200 μM) alone produced nearly 100% toxi-
city and no protection was observed for the levels of
GSH and SCN that represent the CFTR KO ELF. Con-
versely the levels of GSH and SCN that represent the
W TE L Fs h o w e dg o o dp r o t e c t i o nw i t h1 0 0μMG S H
and SCN having 45% LDH release while 250 μMG S H
and 175 μM SCN decreased the toxicity of HOCl to
only 25% LDH release. These data suggest that there is
a large dynamic range of protection against HOCl from
the GSH and SCN levels associated with the WT ELF
but a much smaller degree of protection in the GSH
and SCN levels associated with the CFTR KO ELF.
Discussion
A defining characteristic of CF is exaggerated inflamma-
tion and oxidative stress in the lungs of individuals with
this fatal genetic disease [21]. A large fraction of indivi-
duals with CF harbor chronic infections with pathogens
such as Pseudomonas aeruginosa, which thrive in the
excess mucus secretions found in CF airways [7]. This
excess mucus not only facilitates bacterial growth but it
also makes it difficult for the immune response to eradi-
cate the infection. This constant battle between the
chronic pathogen exposure and immune response is a
contributing factor to the excessive inflammation seen in
the CF airways. Along with increases in inflammatory
cytokines in the airways, there is an excessive neutrophil
infiltration that is a major source of MPO. MPO utilizes
H2O2 and Cl
- to form HOCl, a highly damaging oxidant
that has known antibacterial properties [9]. Under nor-
mal circumstances the lung is well protected by its anti-
oxidant defenses, yet the lack of CFTR impairs the lung’s
ability to maintain high levels of antioxidants in the ELF
which could eventually result in lung damage (Fig 6) [5].
Although GSH is the main extracellular antioxidant
exported by lung epithelium, SCN is also exported and
Figure 5 GSH and SCN levels found in the ELF are sufficient to
protect against HOCl mediated toxicity in vitro. A549 cells were
exposed to 750 μM HOCl (A) or 1200 μM (B) for 5 minutes and
various concentrations of GSH and SCN were used in combination
to determine if they were sufficient to provide protection against
HOCl mediated toxicity assessed by %LDH release 24 hour after
HOCl exposure. The combination of 100 μM GSH and 100 μM SCN
represents basal levels found in the unexposed WT ELF, 250 μM
GSH and 175 μM SCN represents WT hypertonic saline exposed
levels, 50 μM GSH and 25 μM SCN represents CFTR KO unexposed
basal levels, and 100 μM GSH and 25 μM SCN represents CFTR KO
hypertonic saline exposed levels. Data presented as mean ± SEM,
*p ≤ 0.05, ***p ≤ 0.001 compared to control.
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Cl
- in the MPO catalyzed reactions to form HOSCN,
an antimicrobial that is much less damaging than
HOCl [23]. In this sense SCN is not necessarily acting
as an antioxidant, but our lab and others have shown
the antioxidant properties of SCN by directly reacting
with HOCl to detoxify it (unpublished data) [24]. In
the present study, the toxicity of both MPO and HOCl
a l o n ew e r ec o m p a r e da n df o u n dt h a t7 5 0μMH O C l
elicits comparable toxicity to the MPO system. The
total amount of MPO used in the in vitro systems is
comparable to the MPO activity measured in lung
i n f e c t i o nm o d e l sa sw e l la si s o l a t e ds p u t u mf r o mC F
patients [25,26]. Unfortunately direct measurement of
HOCl in the airways has not been done and would be
difficult since HOCl is quite reactive. Based on MPO
activities from sputum of CF patients, HOCl concen-
trations have been estimated to average 2.65 mM [27].
While the actual levels of HOCl that MPO generates
in the airways is not known, it is conceivable that in
isolated microenvironments the concentration of HOCl
could easily reach at least 750 μM during infection or
disease. In addition, the use of HOCl alone excluded
any direct effects that either GSH or SCN may have
Figure 6 Illustration depicting the potential role of hypertonic saline mediated changes in GSH and SCN levels and protection against
HOCl mediated lung injury. The normal airways (A) have the ability to export large amounts of both GSH and SCN into the ELF through CFTR
and an unknown transporter to detoxify the relatively low amount of HOCl produced from neutrophil derived MPO. Whereas in the CF airways
(B) there is a large excess of MPO producing higher amounts of HOCl. Consequently the deficiency in CFTR leads to lower levels of both GSH
and SCN in the ELF which is not fully sufficient at protecting against lung injury.
Gould et al. Respiratory Research 2010, 11:119
http://respiratory-research.com/content/11/1/119
Page 7 of 10on the MPO system or toxicity that may occur due to
H2O2.
CFTR is currently the only known apical transporter
in the lung epithelium that maintains GSH levels in the
ELF [1]. As such, a deficiency in CFTR leads to
decreased extracellular GSH and impairs GSH export,
which is an important lung adaptive response to envir-
onmental agents. SCN has also been shown to be trans-
ported through CFTR, however the exact mechanism of
how this occurs is still poorly understood [22]. The cur-
rent study shows that an in vitro and in vivo deficiency
in CFTR leads to lower levels of extracellular GSH and
SCN. In addition, these studies show the lack of extra-
cellular GSH and SCN may sensitize CFTR deficient
cells to HOCl mediated toxicity. Although the CFTR
KO mouse utilized in this study does not develop spon-
taneous lung disease, it is an ideal model system to
examine the effects of CFTR transport deficiency with-
out the confounding effects of lung damage and excess
inflammation.
Nebulized hypertonic saline has been used for years as
a sputum inducing agent in not only CF but also COPD
and asthma [10,28,29]. Recently the effects of hypertonic
saline in CF individuals have shown marked improve-
ments in lung function [30]. The improvements in lung
function due to hypertonic saline are currently contribu-
ted to airway fluid hydration but the exact reason is not
well understood. Mutations in CFTR result in decreased
fluid secretions and an increased fluid reabsorption lead-
ing to mucus dehydration [31]. Inhalation of hypertonic
saline creates an osmotic gradient that pulls water into
the airways, effectively hydrating the ELF, however the
current studies would also suggest that hypertonic saline
also increases extracellular levels of GSH and SCN.
Improved mucus clearance, lung function, and reduced
exacerbations have been linked to hypertonic saline
treatment without serious adverse effects [4,10].
The source of SCN is commonly thought to be mainly
dietary or as a metabolite of cyanide detoxification cata-
lyzed by rhodenase [32,33]. SCN seems to be highly
r e g u l a t e di nt h a ti ti sk e p ta th i g hc o n c e n t r a t i o n si nt h e
extracellular space in much the same manner as GSH. It
is unlike GSH in that the intracellular levels of SCN are
lower in the intracellular compartment than in the
extracellular space. The current studies suggest that the
increase in SCN in the ELF with hypertonic saline is
most likely not due to any differences in dietary uptake,
which would indicate that the lung epithelium posses
the ability to synthesize SCN or that there is a pool of
readily available SCN for release. This point was best
illustrated in cultured cells where a dietary source could
not account for the differences in SCN levels. Seconda-
rily in the CFTR KO mice there is an increase in SCN
in the lung tissue of the unexposed mice compared to
the WT mice, but upon either isotonic or hypertonic
saline exposure the intracellular SCN returns to the nor-
m a lW Tl e v e l s .T h e r ec o u l db ean u m b e ro fe x p l a n a -
tions for this occurrence, but it is possible that the
hypertonic saline induces a recycling pathway for the
excess SCN to be utilized for the synthesis of other
compounds, possibly even GSH, when it can not be
exported through CFTR. Unfortunately there is not
much known about the regulation of SCN production
and it requires further investigation.
While CFTR may be one of the only known apical
transporters of GSH in the lung, the present studies
show that there is still an increase in ELF GSH with the
hypertonic saline treatment in the CFTR KO mice,
although not nearly to the same degree as the WT sug-
gesting other apical GSH transporters. The current stu-
dies show that even small increases in ELF GSH
observed in the hypertonic exposed CFTR KO mice can
still have protective effects against HOCl mediated toxi-
city, although not nearly to the same degree as occurs
in the WT ELF. There is also previous work to suggest
that osmotic stress can cause the maturation of CFTR,
allowing it to reach the plasma membrane [34]. Hyper-
tonic saline produces a transient osmotic stress and
investigators have shown that osmotic agents such as
sorbitol and myo-inositiol can cause maturation of
ΔF508 CFTR, a trafficking mutation, leading to func-
t i o n a lC F T Ra tt h ep l a s m am e m b r a n e[ 3 5 ] .W h i l et h e
ΔF508 mutant may be the most common mutation of
C F T R ,i ti sb yn om e a n st h eo n l yo n e .T h eC F T RK O
mice utilized in this study possess the S489X truncation
mutation resulting in a non functional CFTR. The pre-
sent studies show that despite having a non functional
CFTR one can increase ELF GSH with hypertonic saline
exposure. This would indicate that anyone with CF,
independent of the type of mutation, may benefit from
hypertonic saline treatment yet those who still have the
functional ΔF508 mutation may benefit the most.
In contrast to GSH, the effect that hypertonic saline
has on SCN is clearly heavily dependent on functional
CFTR. Again, CF individuals carrying the ΔF508 traf-
ficking mutation may benefit more from hypertonic sal-
ine than those without non-trafficking CFTR mutation.
The present study demonstrates that ELF SCN is only
increased in the WT but not the CFTR KO mice when
exposed to hypertonic saline. This would suggest that
while hypertonic saline may be beneficial for some anti-
oxidants like GSH in CF, it doesn’t increase others like
SCN. In addition, since SCNi si n v o l v e di nt h eM P O
mediated production of HOSCN, an antimicrobial,
hypertonic saline may help with the host defense protec-
tion. This would suggest that hypertonic saline may be
beneficial in other inflammatory lung diseases where
there is functional CFTR, like COPD or asthma.
Gould et al. Respiratory Research 2010, 11:119
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may not work for advanced stages of COPD, it may be
beneficial for those with early stage, or mild COPD [36].
There are numerous lung diseases that cause excessive
oxidative stress and inflammation where the ability to
increase both GSH and SCN with hypertonic saline
treatment may be beneficial. While currently there are
no studies that have shown a beneficial effect of hyper-
tonic saline in diseases other than CF, the present study
warrants further investigation of the potential mechan-
isms of this currently available beneficial therapy in
other lung diseases.
Conclusions
Hypertonic saline, a common therapeutic for CF,
induces an increase in both GSH and SCN in the ELF.
While hypertonic saline does increase GSH in CFTR
KO mice, SCN is much more dependent on CFTR for
export. The increases in both GSH and SCN from can
protect airway epithelium from HOCl mediated injury.
These findings indicate another therapeutic benefit of
hypertonic saline, apart from hydration of the airways, is
through increasing airway antioxidant levels and pro-
tecting against endogenously formed oxidants.
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